Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

Condition:   Acne Vulgaris Interventions:   Drug: Clascoterone 1% Top Cream;   Drug: Vehicle Sponsor:   Stanford University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials